Cargando…
Serious hepatotoxicity following use of isoniazid preventive therapy in HIV patients in Eritrea
WHO information note indicates that isoniazid preventive therapy (IPT) is generally safe with little risk of hepatotoxicity. However, when the policy of IPT for HIV patients was introduced in Eritrea, frequent IPT‐associated hepatotoxicity and fatality have been reported to the Pharmacovigilance Cen...
Autores principales: | Russom, Mulugeta, Debesai, Merhawi, Zeregabr, Mehari, Berhane, Araia, Tekeste, Theodros, Teklesenbet, Teklezghi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6066797/ https://www.ncbi.nlm.nih.gov/pubmed/30073087 http://dx.doi.org/10.1002/prp2.423 |
Ejemplares similares
-
Effectiveness of a 6-Month Isoniazid on Prevention of Incident Tuberculosis Among People Living with HIV in Eritrea: A Retrospective Cohort Study
por: Russom, Mulugeta, et al.
Publicado: (2022) -
Liver Injury Following Isoniazid Preventive Therapy in HIV Patients Attending Halibet National Referral Hospital, Eritrea: A Prospective Cohort Study
por: Russom, Mulugeta, et al.
Publicado: (2023) -
Risk Factors of Gout in MDR-TB Patients in Eritrea: A Case-Control Study
por: Russom, Mulugeta, et al.
Publicado: (2019) -
Knowledge, attitude and practice of antibiotics and their determinants in Eritrea: an urban population-based survey
por: Russom, Mulugeta, et al.
Publicado: (2021) -
Praziquantel and risk of visual disorders: Case series assessment
por: Debesai, Merhawi, et al.
Publicado: (2020)